3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
1
Solitary Fibrous Tumor, Pleural
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adult Patients Who Are Receiving Oncologic Care
1
Interventions
pembrolizumab
44
Carboplatin
35
Paclitaxel
27
Specimen Handling
18
Cyclophosphamide
16
Capecitabine
16
Magnetic Resonance Spectroscopy
14
sacituzumab govitecan
13
Gemcitabine
13
Taxes
12
Biopsy
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
Doxorubicin
8
olaparib
7
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Fulvestrant
4
Epirubicin
4
Bevacizumab
4
veliparib
3
famitinib
3
abemaciclib
3
Vinorelbine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Pharmacogenomic Testing
×
90 days
×
Clear all
No trials found.